Xingyu Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xingyu Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chunhui Song
Key Laboratory of Biodiversity Conservation and Bioresource Utilization of Jiangxi Province, College of Life Sciences, Jiangxi Normal University, Nanchang 330022, China
3 shared publications - Yunchang Xie
Key Laboratory of Biodiversity Conservation and Bioresource Utilization of Jiangxi Province, College of Life Sciences, Jiangxi Normal University, Nanchang 330022, China
3 shared publications - Leshan Ruan
College of Marine Sciences, South China Agricultural University, Guangzhou 510642, China
2 shared publications - Lifang Cao
College of Marine Sciences, South China Agricultural University, Guangzhou 510642, China
2 shared publications - Shina Wei
College of Marine Sciences, South China Agricultural University, Guangzhou 510642, China
2 shared publications - Yewen Wang
Key Laboratory of Biodiversity Conservation and Bioresource Utilization of Jiangxi Province, College of Life Sciences, Jiangxi Normal University, Nanchang 330022, China
2 shared publications
Latest Publications
- Open Access
- 18 December 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (12) , 2871
Mining of Novkitasetaline, a New Sulfur-Containing Antimalarial β-Carboline Alkaloid, from Streptomyces sp. PRh3 by Functional Ribosome Engineering Directed Heterologous Expression
The endophytic Streptomyces sp. PRh3 (PRh3), isolated from Dongxiang wild rice (DXWR), exhibited impaired biosynthetic capacity in the laboratory. To address this defect, rifampicin-based ribosome engineering was first applied to PRh3 to generate PRh3-r55, which acquired a characteristic H473Y rifampicin-resistant mutation in rpoB to activate the production of two β-carboline alkaloids JBIR-133 and JBIR-134. Then the biosynthetic gene cluster (BGC) ksl was introduced into PRh3-r55 for heterologous expression, generating PRh3-r55K. This combined approach achieved a synergistic effect, enabling the strain to produce not only the expected JBIR-133, JBIR-134, and kitasetaline, but also a novel sulfur-containing molecule, novkitasetaline. Structural elucidation identified novkitasetaline as a unique tryptamine-substituted kitasetaline derivative at the C-3 position of its pyridine ring. Notably, this structural modification conferred significant antimalarial activity to novkitasetaline, rendering it active against drug-sensitive Plasmodium falciparum 3D7 (IC50 = 32.65 ± 2.93 μM) and three other drug-resistant P. falciparum strains: K13C580Y, Dd2, and HB3 (IC50 = 45.98 ± 4.17~59.67 ± 3.15 μM), primarily by disrupting late-stage parasite development. These efforts not only identified a promising antimalarial lead compound but also demonstrated that combining ribosome engineering with heterologous expression is an effective strategy for discovering bioactive natural products from Streptomyces.
- 18 December 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (12) , 2871
Open AccessMining of Novkitasetaline, a New Sulfur-Containing Antimalarial β-Carboline Alkaloid, from Streptomyces sp. PRh3 by Functional Ribosome Engineering Directed Heterologous Expression
The endophytic Streptomyces sp. PRh3 (PRh3), isolated from Dongxiang wild rice (DXWR), exhibited impaired biosynthetic capacity in the laboratory. To address this defect, rifampicin-based ribosome engineering was first applied to PRh3 to generate PRh3-r55, which acquired a characteristic H473Y rifampicin-resistant mutation in rpoB to activate the production of two β-carboline alkaloids JBIR-133 and JBIR-134. Then the biosynthetic gene cluster (BGC) ksl was introduced into PRh3-r55 for heterologous expression, generating PRh3-r55K. This combined approach achieved a synergistic effect, enabling the strain to produce not only the expected JBIR-133, JBIR-134, and kitasetaline, but also a novel sulfur-containing molecule, novkitasetaline. Structural elucidation identified novkitasetaline as a unique tryptamine-substituted kitasetaline derivative at the C-3 position of its pyridine ring. Notably, this structural modification conferred significant antimalarial activity to novkitasetaline, rendering it active against drug-sensitive Plasmodium falciparum 3D7 (IC50 = 32.65 ± 2.93 μM) and three other drug-resistant P. falciparum strains: K13C580Y, Dd2, and HB3 (IC50 = 45.98 ± 4.17~59.67 ± 3.15 μM), primarily by disrupting late-stage parasite development. These efforts not only identified a promising antimalarial lead compound but also demonstrated that combining ribosome engineering with heterologous expression is an effective strategy for discovering bioactive natural products from Streptomyces.
- Open Access
- 30 September 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (10) , 2281
Antiviral Activity of Eugenol Against Largemouth Bass Ranavirus Through Regulation of Autophagy and Apoptosis In Vitro and In Vivo
Largemouth bass ranavirus (LMBV) causes high mortality rate in largemouth bass during outbreaks, resulting in huge economic losses. Eugenol (EUG) has potent antiviral activity, showing promising potential against LMBV. Thus, to investigate EUG’s efficacy against LMBV, corresponding analysis was conducted in vivo and in vitro. Firstly, EUG demonstrated to be able to down-regulate both the mRNA and protein levels of the major capsid protein (MCP) in LMBV-infected cells. In addition, EUG could inhibit the expression of cleaved-caspase-3 in LMBV-infected fathead minnow (FHM) cell. On the other hand, EUG would not only directly regulate the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway but also affect the AMP-activated protein kinase (AMPK) pathway in FHM cells during LMBV infection. These results indicated that EUG exerts its antiviral effects by modulating both LMBV-induced apoptosis and autophagy. Notably, EUG reduced the viral load present within the tissues of LMBV-infected largemouth bass, thereby ultimately enhancing their survival rate in the culture environment by about 20%. These mechanistic assays revealed the anti-LMBV properties of EUG, which could significantly enrich the research content of plant extracts in the field of aquatic antiviral, and provide important theoretical basis for the development and application of related products.
- 30 September 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (10) , 2281
Open AccessAntiviral Activity of Eugenol Against Largemouth Bass Ranavirus Through Regulation of Autophagy and Apoptosis In Vitro and In Vivo
Largemouth bass ranavirus (LMBV) causes high mortality rate in largemouth bass during outbreaks, resulting in huge economic losses. Eugenol (EUG) has potent antiviral activity, showing promising potential against LMBV. Thus, to investigate EUG’s efficacy against LMBV, corresponding analysis was conducted in vivo and in vitro. Firstly, EUG demonstrated to be able to down-regulate both the mRNA and protein levels of the major capsid protein (MCP) in LMBV-infected cells. In addition, EUG could inhibit the expression of cleaved-caspase-3 in LMBV-infected fathead minnow (FHM) cell. On the other hand, EUG would not only directly regulate the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway but also affect the AMP-activated protein kinase (AMPK) pathway in FHM cells during LMBV infection. These results indicated that EUG exerts its antiviral effects by modulating both LMBV-induced apoptosis and autophagy. Notably, EUG reduced the viral load present within the tissues of LMBV-infected largemouth bass, thereby ultimately enhancing their survival rate in the culture environment by about 20%. These mechanistic assays revealed the anti-LMBV properties of EUG, which could significantly enrich the research content of plant extracts in the field of aquatic antiviral, and provide important theoretical basis for the development and application of related products.
- Open Access
- 13 August 2025
- Published by MDPI AG in Preprints.org
Antiviral Role of Eugenol Against Largemouth Bass Ranavirus Infection
Largemouth bass ranavirus (LMBV) is a severely harmful pathogen in the largemouth bass culture industry. This virus causes high mortality rate in largemouth bass during its epidemic season, resulting in huge economic losses. While, eugenol (EUG) has potent antiviral activity showing promising potential to against LMBV. Thus, to investigated EUG’s efficacy against LMBV, an analysis of the autophagy and apoptosis was conducted and confirmed the anti-LMBV activity of EUG in vivo and in vitro. Firstly, EUG can not only directly inhibit the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway, but also promote the AMP-activated protein kinase (AMPK) pathway in fathead minnow (FHM) cells during LMBV infection. This effect has the capacity to activate and enhance the autophagy of the FHM cells against its apoptosis that has been induced by LMBV. Notably, EUG reduced the viral load present within the tissues of LMBV-infected largemouth bass, thereby ultimately enhancing their survival rate within a culture setting. These mechanistic assays revealed the anti-LMBV properties of EUG, which could significantly enrich the content of antiviral research and provide valuable references for aquaculture.
- 13 August 2025
- Published by MDPI AG in Preprints.org
Open AccessAntiviral Role of Eugenol Against Largemouth Bass Ranavirus Infection
Largemouth bass ranavirus (LMBV) is a severely harmful pathogen in the largemouth bass culture industry. This virus causes high mortality rate in largemouth bass during its epidemic season, resulting in huge economic losses. While, eugenol (EUG) has potent antiviral activity showing promising potential to against LMBV. Thus, to investigated EUG’s efficacy against LMBV, an analysis of the autophagy and apoptosis was conducted and confirmed the anti-LMBV activity of EUG in vivo and in vitro. Firstly, EUG can not only directly inhibit the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway, but also promote the AMP-activated protein kinase (AMPK) pathway in fathead minnow (FHM) cells during LMBV infection. This effect has the capacity to activate and enhance the autophagy of the FHM cells against its apoptosis that has been induced by LMBV. Notably, EUG reduced the viral load present within the tissues of LMBV-infected largemouth bass, thereby ultimately enhancing their survival rate within a culture setting. These mechanistic assays revealed the anti-LMBV properties of EUG, which could significantly enrich the content of antiviral research and provide valuable references for aquaculture.